TMDX TransMedics Group, Inc.

NASDAQ
$91.38

TransMedics Group, Inc. (TMDX) is expected to report earnings on February 4, 2027, after the market close. The consensus earnings estimate is $0.41 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +15.5% since its last earnings release on November 5, 2026.

TransMedics Group Beat Consensus Estimates, Raises Guidance
Thursday, November 5, 2026 · 4:02 PM ET
Earnings Date
4th Quarter, Dec 2026
Feb 4
Thursday · 4:00 PM ET
Earnings Whisper
-
vs $0.41
Rev est $200.02M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $90.72

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About TransMedics Group, Inc.

TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation.

Sector

Healthcare

Industry

Medical Appliances/Equipment

Charts powered in part by Lightweight Charts™ by TradingView.